We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
An SI Board Since March 1998
Posts SubjectMarks Bans Symbol
255 21 0 ARDM
Emcee:  Marvin Frank Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
205Recent freebie editorial on inhaled insulin: Notable for ttuck-5/26/2004
204There is just no way of knowing. I'm convinced not even novo knows. But thkeokalani'nui-5/5/2004
203Hi Wilder, Sorry I wasn't trying to put words in your mouth. I was only tryArea51-5/5/2004
202I have no idea why you think I think this drug has a <50% chance of success ikeokalani'nui-5/5/2004
201<<Could be that this is limited to T1, as they have substantially more cirArea51-5/5/2004
200Ardm also found in its early studies that the aerosolized insulin was more fast keokalani'nui-5/2/2004
199[Impact of particle size and aerosolization time on the metabolic effect of an ituck-5/2/2004
198Having listened to novo's and ardm's cc: 1. Both companies believe it keokalani'nui-4/30/2004
197>>during the nighttime, plasma glucose levels were lower in the AERx iDMS keokalani'nui-4/30/2004
196Bummer. I still think ardm may have a better mousetrap than nktr. But ardm can&#rkrw-4/30/2004
195Better for Nektar or Aerogen, I guess. >>HAYWARD, Calif., April 30 /PRNewtuck-4/30/2004
194Was todays ardm announcement good news or bad news? Here's yet another inhrkrw-4/30/2004
193I spoke with our family D.O. and he was really impressed. Thought it was a novelTadsamillionaire-4/2/2004
192This may or may not mean anything - I mentioned inhalable insulin to my family pidler-3/30/2004
191While we wait for Godot . . . >>Diabetes. 2004 Apr;53(4):877-81. tuck-3/30/2004
190Upgrade yesterday . . . >>Punk Ziegel upgrades Aradigm Corp to Accumultuck-2/13/2004
189Well, the only documents I can find that seem to relate to this predate Novo'tuck-1/18/2004
188<i>So why are those two predicting an Exubera NDA this year?</i> Unnigel bates-1/18/2004
187>>Drugs R D. 2004; 5(1): 46-49. Insulin inhalation: NN 1998. [No authotuck-1/18/2004
186Also in preclinical stage is Elan . . . >>Int J Pharm. 2004 Jan 28;tuck-1/7/2004
185These guys are long way from the market, but worth noting as competition . . . tuck-12/8/2003
184>>HAYWARD, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Aradigm Corporation (tuck-12/1/2003
183>>Arch Intern Med. 2003 Oct 27;163(19):2277-82. Inhaled insulin providetuck-10/29/2003
182PFE still vague on Exubera filing. Concurrently, big volume in ARDM today, withtuck-10/22/2003
181>>J Clin Pharmacol. 2003 Nov;43(11):1228-34. Young and Elderly Type 2 Dtuck-10/13/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):